| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyCellularComponent | vesicle coat | 6.81e-05 | 67 | 133 | 5 | GO:0030120 | |
| GeneOntologyCellularComponent | AP-2 adaptor complex | 8.71e-05 | 14 | 133 | 3 | GO:0030122 | |
| GeneOntologyCellularComponent | clathrin coat of endocytic vesicle | 1.08e-04 | 15 | 133 | 3 | GO:0030128 | |
| GeneOntologyCellularComponent | clathrin coat of coated pit | 3.08e-04 | 21 | 133 | 3 | GO:0030132 | |
| GeneOntologyCellularComponent | membrane coat | 5.86e-04 | 106 | 133 | 5 | GO:0030117 | |
| GeneOntologyCellularComponent | coated membrane | 5.86e-04 | 106 | 133 | 5 | GO:0048475 | |
| GeneOntologyCellularComponent | central region of growth cone | 8.26e-04 | 7 | 133 | 2 | GO:0090724 | |
| GeneOntologyCellularComponent | clathrin adaptor complex | 9.93e-04 | 31 | 133 | 3 | GO:0030131 | |
| Domain | - | 4.59e-05 | 2 | 127 | 2 | 2.60.40.1030 | |
| Domain | Clathrin_a-adaptin_app_Ig-like | 4.59e-05 | 2 | 127 | 2 | IPR013038 | |
| Domain | LYZL1/LYZL2 | 4.59e-05 | 2 | 127 | 2 | IPR030057 | |
| Domain | AP2_complex_asu | 4.59e-05 | 2 | 127 | 2 | IPR017104 | |
| Domain | Clathrin_a-adaptin_app_sub_C | 4.59e-05 | 2 | 127 | 2 | IPR003164 | |
| Domain | Alpha_adaptin_C | 4.59e-05 | 2 | 127 | 2 | PF02296 | |
| Domain | TRAM1 | 1.37e-04 | 3 | 127 | 2 | PF08390 | |
| Domain | Fox-1_C | 1.37e-04 | 3 | 127 | 2 | PF12414 | |
| Domain | Sox_C | 1.37e-04 | 3 | 127 | 2 | IPR021934 | |
| Domain | Fox-1_C_dom | 1.37e-04 | 3 | 127 | 2 | IPR025670 | |
| Domain | Sox7/17/18_central | 1.37e-04 | 3 | 127 | 2 | IPR033392 | |
| Domain | Sox17_18_mid | 1.37e-04 | 3 | 127 | 2 | PF12067 | |
| Domain | RNA-bd_Fox-1 | 1.37e-04 | 3 | 127 | 2 | IPR017325 | |
| Domain | Translocation_assoc_membrane | 1.37e-04 | 3 | 127 | 2 | IPR016447 | |
| Domain | SOX_C | 1.37e-04 | 3 | 127 | 2 | PS51516 | |
| Domain | TRAM1 | 1.37e-04 | 3 | 127 | 2 | IPR013599 | |
| Domain | P4Hc | 1.61e-04 | 16 | 127 | 3 | SM00702 | |
| Domain | Pro_4_hyd_alph | 1.61e-04 | 16 | 127 | 3 | IPR006620 | |
| Domain | Clathrin_a/coatomer_app_sub_C | 2.73e-04 | 4 | 127 | 2 | IPR015873 | |
| Domain | - | 2.73e-04 | 4 | 127 | 2 | 3.30.310.30 | |
| Domain | FE2OG_OXY | 3.73e-04 | 21 | 127 | 3 | PS51471 | |
| Domain | Oxoglu/Fe-dep_dioxygenase | 4.92e-04 | 23 | 127 | 3 | IPR005123 | |
| Domain | MFS | 8.56e-04 | 108 | 127 | 5 | PS50850 | |
| Domain | Glyco_hydro_22_lys | 9.42e-04 | 7 | 127 | 2 | IPR000974 | |
| Domain | Glyco_hydro_22_CS | 9.42e-04 | 7 | 127 | 2 | IPR019799 | |
| Domain | GoLoco | 9.42e-04 | 7 | 127 | 2 | SM00390 | |
| Domain | GoLoco | 9.42e-04 | 7 | 127 | 2 | PF02188 | |
| Domain | GoLoco_motif | 9.42e-04 | 7 | 127 | 2 | IPR003109 | |
| Domain | GOLOCO | 9.42e-04 | 7 | 127 | 2 | PS50877 | |
| Domain | Coatomer/calthrin_app_sub_C | 1.25e-03 | 8 | 127 | 2 | IPR009028 | |
| Domain | Glyco_hydro_22 | 1.25e-03 | 8 | 127 | 2 | IPR001916 | |
| Domain | LACTALBUMIN_LYSOZYME_2 | 1.25e-03 | 8 | 127 | 2 | PS51348 | |
| Domain | Lys | 1.25e-03 | 8 | 127 | 2 | PF00062 | |
| Domain | LACTALBUMIN_LYSOZYME_1 | 1.25e-03 | 8 | 127 | 2 | PS00128 | |
| Domain | LYZ1 | 1.25e-03 | 8 | 127 | 2 | SM00263 | |
| Domain | Alpha_adaptinC2 | 1.60e-03 | 9 | 127 | 2 | PF02883 | |
| Domain | Clathrin_a/b/g-adaptin_app_Ig | 1.60e-03 | 9 | 127 | 2 | IPR008152 | |
| Domain | Alpha_adaptinC2 | 1.60e-03 | 9 | 127 | 2 | SM00809 | |
| Domain | MFS_sugar_transport-like | 1.86e-03 | 36 | 127 | 3 | IPR005828 | |
| Domain | Sugar_tr | 1.86e-03 | 36 | 127 | 3 | PF00083 | |
| Domain | Lysozyme-like_dom | 1.99e-03 | 10 | 127 | 2 | IPR023346 | |
| Domain | MFS_dom | 2.23e-03 | 134 | 127 | 5 | IPR020846 | |
| Domain | DUF1220 | 2.42e-03 | 11 | 127 | 2 | PF06758 | |
| Domain | Integrin_alpha | 2.42e-03 | 11 | 127 | 2 | PF00357 | |
| Domain | 2OG-FeII_Oxy_3 | 2.42e-03 | 11 | 127 | 2 | PF13640 | |
| Domain | NBPF_dom | 2.42e-03 | 11 | 127 | 2 | IPR010630 | |
| Domain | NBPF | 2.42e-03 | 11 | 127 | 2 | PS51316 | |
| Pathway | REACTOME_CARGO_RECOGNITION_FOR_CLATHRIN_MEDIATED_ENDOCYTOSIS | 3.64e-05 | 102 | 86 | 6 | MM15498 | |
| Pathway | REACTOME_CARGO_RECOGNITION_FOR_CLATHRIN_MEDIATED_ENDOCYTOSIS | 4.29e-05 | 105 | 86 | 6 | M27752 | |
| Pathway | REACTOME_MEMBRANE_TRAFFICKING | COPZ1 COPS7A SEC24D AP2A1 AP2A2 SLC18A3 RIN2 RAB43 PAFAH1B1 DENND2C ITSN2 FTL TOR1B | 1.08e-04 | 630 | 86 | 13 | M11480 |
| Pathway | REACTOME_VESICLE_MEDIATED_TRANSPORT | COPZ1 COPS7A SEC24D AP2A1 AP2A2 SLC18A3 RIN2 RAB43 PAFAH1B1 DENND2C ITSN2 FTL TOR1B | 1.36e-04 | 645 | 86 | 13 | MM15232 |
| Pathway | WP_CELL_LINEAGE_MAP_FOR_NEURONAL_DIFFERENTIATION | 1.53e-04 | 132 | 86 | 6 | M48110 | |
| Pathway | REACTOME_MECP2_REGULATES_NEURONAL_RECEPTORS_AND_CHANNELS | 1.67e-04 | 18 | 86 | 3 | M27901 | |
| Pathway | REACTOME_CLATHRIN_MEDIATED_ENDOCYTOSIS | 2.28e-04 | 142 | 86 | 6 | MM15499 | |
| Pathway | REACTOME_CLATHRIN_MEDIATED_ENDOCYTOSIS | 2.55e-04 | 145 | 86 | 6 | M27753 | |
| Pubmed | 1.89e-10 | 21 | 139 | 6 | 16079250 | ||
| Pubmed | Expression of testicular germ cell genes identified by differential display analysis. | 1.69e-08 | 8 | 139 | 4 | 12634303 | |
| Pubmed | 6.21e-07 | 5 | 139 | 3 | 15355796 | ||
| Pubmed | RBM4 HUWE1 RFX1 SOX7 SEC24D AP2A1 AP2A2 TENM3 CDK13 SECISBP2 FTL BAG6 | 4.88e-06 | 591 | 139 | 12 | 15231748 | |
| Pubmed | Evolutionary history and genome organization of DUF1220 protein domains. | 7.34e-06 | 10 | 139 | 3 | 22973535 | |
| Pubmed | The splicing regulator Rbfox2 is required for both cerebellar development and mature motor function. | 9.14e-06 | 33 | 139 | 4 | 22357600 | |
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 18682240 | ||
| Pubmed | Cloning of cDNAs encoding two related 100-kD coated vesicle proteins (alpha-adaptins). | 1.59e-05 | 2 | 139 | 2 | 2564002 | |
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 24039908 | ||
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 22132182 | ||
| Pubmed | Expression of sucrase-isomaltase and dipeptidylpeptidase IV in human small intestine and colon. | 1.59e-05 | 2 | 139 | 2 | 1677636 | |
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 11832491 | ||
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 20172014 | ||
| Pubmed | Cloning, physical mapping and structural characterization of the human alpha(A)-adaptin gene. | 1.59e-05 | 2 | 139 | 2 | 12036598 | |
| Pubmed | Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity. | TRAF7 RAF1 ERCC3 RBFOX3 ADCK1 MAP3K20 CYFIP1 AP2A1 AP2A2 CDK13 RIN2 RBFOX1 PLOD1 IPMK | 1.82e-05 | 910 | 139 | 14 | 36736316 |
| Pubmed | Depletion of definitive gut endoderm in Sox17-null mutant mice. | 2.20e-05 | 14 | 139 | 3 | 11973269 | |
| Pubmed | METTL3 protects METTL14 from STUB1-mediated degradation to maintain m6 A homeostasis. | 4.23e-05 | 231 | 139 | 7 | 36597993 | |
| Pubmed | 4.75e-05 | 3 | 139 | 2 | 34039076 | ||
| Pubmed | 4.75e-05 | 3 | 139 | 2 | 35014951 | ||
| Pubmed | 4.75e-05 | 3 | 139 | 2 | 18032517 | ||
| Pubmed | 4.75e-05 | 3 | 139 | 2 | 26075911 | ||
| Pubmed | 4.75e-05 | 3 | 139 | 2 | 38927638 | ||
| Pubmed | 4.75e-05 | 3 | 139 | 2 | 19328208 | ||
| Pubmed | Retinitis pigmentosa 2 pathogenic mutants degrade through BAG6/HUWE1 complex. | 4.75e-05 | 3 | 139 | 2 | 35569519 | |
| Pubmed | Charting Brachyury-mediated developmental pathways during early mouse embryogenesis. | 4.75e-05 | 3 | 139 | 2 | 24616493 | |
| Pubmed | 4.75e-05 | 3 | 139 | 2 | 20841351 | ||
| Pubmed | 4.75e-05 | 3 | 139 | 2 | 16704374 | ||
| Pubmed | Rbfox family proteins make the homo- and hetero-oligomeric complexes. | 4.75e-05 | 3 | 139 | 2 | 29170129 | |
| Pubmed | Expandable endodermal progenitors: new tools to explore endoderm and its derivatives. | 4.75e-05 | 3 | 139 | 2 | 18940723 | |
| Pubmed | 4.75e-05 | 3 | 139 | 2 | 22262466 | ||
| Pubmed | 4.75e-05 | 3 | 139 | 2 | 26269175 | ||
| Pubmed | Dll4 Blockade Promotes Angiogenesis in Nonhealing Wounds of Sox7-Deficient Mice. | 4.75e-05 | 3 | 139 | 2 | 33095124 | |
| Pubmed | Rbfox Splicing Factors Promote Neuronal Maturation and Axon Initial Segment Assembly. | 4.75e-05 | 3 | 139 | 2 | 29398366 | |
| Pubmed | 4.75e-05 | 3 | 139 | 2 | 32433020 | ||
| Pubmed | 4.75e-05 | 3 | 139 | 2 | 19129443 | ||
| Pubmed | 4.75e-05 | 3 | 139 | 2 | 8617812 | ||
| Pubmed | 4.75e-05 | 3 | 139 | 2 | 37845385 | ||
| Pubmed | The ear of alpha-adaptin interacts with the COOH-terminal domain of the Eps 15 protein. | 4.75e-05 | 3 | 139 | 2 | 8662627 | |
| Pubmed | 4.88e-05 | 18 | 139 | 3 | 25569111 | ||
| Pubmed | 5.78e-05 | 19 | 139 | 3 | 31959764 | ||
| Pubmed | 9.10e-05 | 22 | 139 | 3 | 35245678 | ||
| Pubmed | Disruption of the murine Ap2β1 gene causes nonsyndromic cleft palate. | 9.47e-05 | 4 | 139 | 2 | 20500056 | |
| Pubmed | Redundant roles of Sox17 and Sox18 in early cardiovascular development of mouse embryos. | 9.47e-05 | 4 | 139 | 2 | 17610846 | |
| Pubmed | Mammalian Pins is a conformational switch that links NuMA to heterotrimeric G proteins. | 9.47e-05 | 4 | 139 | 2 | 15537540 | |
| Pubmed | Homologues of the Caenorhabditis elegans Fox-1 protein are neuronal splicing regulators in mammals. | 9.47e-05 | 4 | 139 | 2 | 16260614 | |
| Pubmed | 9.47e-05 | 4 | 139 | 2 | 28619820 | ||
| Pubmed | 9.47e-05 | 4 | 139 | 2 | 32153366 | ||
| Pubmed | 9.47e-05 | 4 | 139 | 2 | 8661054 | ||
| Pubmed | 9.47e-05 | 4 | 139 | 2 | 12646615 | ||
| Pubmed | 9.47e-05 | 4 | 139 | 2 | 16210401 | ||
| Pubmed | α4 β1 integrin promotes accumulation of tissue-resident memory CD8+ T cells in salivary glands. | 9.47e-05 | 4 | 139 | 2 | 27861803 | |
| Pubmed | DPP-4 exacerbates LPS-induced endothelial cells inflammation via integrin-α5β1/FAK/AKT signaling. | 9.47e-05 | 4 | 139 | 2 | 38184221 | |
| Pubmed | 9.47e-05 | 4 | 139 | 2 | 26861571 | ||
| Pubmed | 9.47e-05 | 4 | 139 | 2 | 15220343 | ||
| Pubmed | 9.47e-05 | 4 | 139 | 2 | 12925752 | ||
| Pubmed | 9.47e-05 | 4 | 139 | 2 | 25524026 | ||
| Pubmed | 9.47e-05 | 4 | 139 | 2 | 21982711 | ||
| Pubmed | 9.47e-05 | 4 | 139 | 2 | 25706747 | ||
| Pubmed | HUWE1 is a molecular link controlling RAF-1 activity supported by the Shoc2 scaffold. | 9.47e-05 | 4 | 139 | 2 | 25022756 | |
| Pubmed | Association and colocalization of Eps15 with adaptor protein-2 and clathrin. | 9.47e-05 | 4 | 139 | 2 | 9049247 | |
| Pubmed | Sox7 promotes high-grade glioma by increasing VEGFR2-mediated vascular abnormality. | 9.47e-05 | 4 | 139 | 2 | 29444818 | |
| Pubmed | 9.47e-05 | 4 | 139 | 2 | 17101796 | ||
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | TRAF7 RBM4 NBPF26 OGFOD3 GLB1L2 ITGA5 LRP1B TENM3 P4HA1 TRAM1 SEL1L3 OSBPL9 TOR1B PRKCSH PLOD1 | 9.73e-05 | 1201 | 139 | 15 | 35696571 |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | DIP2B ACACA RBM4 SLC22A23 ADGRV1 HUWE1 NAALADL2 PTPN4 PTPRR CDK13 RPTOR RIN2 EHF SEL1L3 OSBPL9 CATSPERG PLOD1 | 9.78e-05 | 1489 | 139 | 17 | 28611215 |
| Pubmed | 1.04e-04 | 23 | 139 | 3 | 14662765 | ||
| Pubmed | 1.21e-04 | 63 | 139 | 4 | 34718347 | ||
| Pubmed | 1.35e-04 | 25 | 139 | 3 | 36046192 | ||
| Pubmed | 1.54e-04 | 67 | 139 | 4 | 29357390 | ||
| Pubmed | Fox-3 and PSF interact to activate neural cell-specific alternative splicing. | 1.57e-04 | 5 | 139 | 2 | 21177649 | |
| Pubmed | SoxF Transcription Factors Are Positive Feedback Regulators of VEGF Signaling. | 1.57e-04 | 5 | 139 | 2 | 27528602 | |
| Pubmed | Developmental control of CaV1.2 L-type calcium channel splicing by Fox proteins. | 1.57e-04 | 5 | 139 | 2 | 19564422 | |
| Pubmed | Interaction of HIV-1 Gag with the clathrin-associated adaptor AP-2. | 1.57e-04 | 5 | 139 | 2 | 16139856 | |
| Pubmed | Endocytic Adaptor Proteins in Health and Disease: Lessons from Model Organisms and Human Mutations. | 1.57e-04 | 5 | 139 | 2 | 31671891 | |
| Pubmed | Weak Molecular Interactions in Clathrin-Mediated Endocytosis. | 1.57e-04 | 5 | 139 | 2 | 29184887 | |
| Pubmed | 1.57e-04 | 5 | 139 | 2 | 17108326 | ||
| Pubmed | Epsin is an EH-domain-binding protein implicated in clathrin-mediated endocytosis. | 1.57e-04 | 5 | 139 | 2 | 9723620 | |
| Pubmed | 1.57e-04 | 5 | 139 | 2 | 25802080 | ||
| Pubmed | Analysis of the AP-2 adaptor complex and cargo during clathrin-mediated endocytosis. | 1.57e-04 | 5 | 139 | 2 | 15941406 | |
| Pubmed | A protein-protein interaction map of the TNF-induced NF-κB signal transduction pathway. | 2.23e-04 | 302 | 139 | 7 | 30561431 | |
| Pubmed | 2.35e-04 | 6 | 139 | 2 | 26987813 | ||
| Pubmed | Numb expression and asymmetric versus symmetric cell division in distal embryonic lung epithelium. | 2.35e-04 | 6 | 139 | 2 | 22713487 | |
| Pubmed | Two forms of human Inscuteable-related protein that links Par3 to the Pins homologues LGN and AGS3. | 2.35e-04 | 6 | 139 | 2 | 16458856 | |
| Pubmed | 2.35e-04 | 6 | 139 | 2 | 19703720 | ||
| Pubmed | 2.35e-04 | 6 | 139 | 2 | 24928429 | ||
| Pubmed | 2.35e-04 | 6 | 139 | 2 | 22074847 | ||
| Pubmed | 2.35e-04 | 6 | 139 | 2 | 19515696 | ||
| Pubmed | 2.35e-04 | 6 | 139 | 2 | 10966473 | ||
| Pubmed | SOX7 and GATA-4 are competitive activators of Fgf-3 transcription. | 2.35e-04 | 6 | 139 | 2 | 15082719 | |
| Pubmed | 2.35e-04 | 6 | 139 | 2 | 15020715 | ||
| Pubmed | 2.35e-04 | 6 | 139 | 2 | 22121118 | ||
| Pubmed | 2.35e-04 | 6 | 139 | 2 | 37017303 | ||
| Pubmed | 2.35e-04 | 6 | 139 | 2 | 22650988 | ||
| Pubmed | 2.35e-04 | 6 | 139 | 2 | 12121421 | ||
| Pubmed | Differential cell-type-expression of CYFIP1 and CYFIP2 in the adult mouse hippocampus. | 2.35e-04 | 6 | 139 | 2 | 31853374 | |
| Pubmed | Radmis, a novel mitotic spindle protein that functions in cell division of neural progenitors. | 2.35e-04 | 6 | 139 | 2 | 24260314 | |
| Pubmed | Molecular architecture and functional model of the endocytic AP2 complex. | 2.35e-04 | 6 | 139 | 2 | 12086608 | |
| Pubmed | 2.35e-04 | 6 | 139 | 2 | 29635272 | ||
| Pubmed | 2.35e-04 | 6 | 139 | 2 | 29563520 | ||
| Pubmed | The late and dual origin of cerebrospinal fluid-contacting neurons in the mouse spinal cord. | 2.59e-04 | 31 | 139 | 3 | 26839365 | |
| Pubmed | Identification of phagocytosis regulators using magnetic genome-wide CRISPR screens. | 2.83e-04 | 143 | 139 | 5 | 30397336 | |
| Interaction | ANKRD20A4P interactions | 5.67e-06 | 6 | 134 | 3 | int:ANKRD20A4P | |
| Interaction | ANKRD20A2P interactions | 9.87e-06 | 7 | 134 | 3 | int:ANKRD20A2P | |
| Cytoband | 1q21.1 | 3.92e-05 | 62 | 139 | 4 | 1q21.1 | |
| Cytoband | 4q26 | 3.28e-04 | 44 | 139 | 3 | 4q26 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr4q26 | 6.35e-04 | 55 | 139 | 3 | chr4q26 | |
| GeneFamily | Neuroblastoma breakpoint family | 2.53e-11 | 23 | 98 | 7 | 662 | |
| GeneFamily | Lysozymes, c-type | 1.02e-03 | 9 | 98 | 2 | 1174 | |
| GeneFamily | TLC domain containing | 1.27e-03 | 10 | 98 | 2 | 1374 | |
| Coexpression | BENPORATH_SUZ12_TARGETS | SOX17 ANKRD20A2P GRIK3 ANKRD20A3P ANKRD20A8P FOXA2 CSMD3 IRX4 OPRK1 IL1RAPL1 SOX7 SLITRK2 CYFIP1 ANKRD20A5P SLC18A3 WRAP73 SORCS3 DLX2 ANKRD20A1 | 1.56e-06 | 1035 | 135 | 19 | M9898 |
| Coexpression | BENPORATH_PRC2_TARGETS | SOX17 ANKRD20A2P GRIK3 ANKRD20A3P ANKRD20A8P FOXA2 CSMD3 IRX4 SOX7 ANKRD20A5P WRAP73 SORCS3 DLX2 ANKRD20A1 | 7.00e-06 | 650 | 135 | 14 | M8448 |
| Coexpression | DESCARTES_FETAL_EYE_PDE11A_FAM19A2_POSITIVE_CELLS | 1.45e-05 | 29 | 135 | 4 | M40183 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HPROGM | 3.18e-05 | 307 | 135 | 9 | M39058 | |
| Coexpression | BENPORATH_EED_TARGETS | MCHR2 SOX17 ANKRD20A2P GRIK3 ANKRD20A3P ANKRD20A8P FOXA2 CSMD3 IRX4 SOX7 FNDC1 ANKRD20A5P SLC18A3 WRAP73 SORCS3 DLX2 ANKRD20A1 | 3.26e-05 | 1059 | 135 | 17 | M7617 |
| ToppCell | mLN-(5)_Dendritic_cell-(53)_Lymphoid_DC|mLN / shred on region, Cell_type, and subtype | PLBD1 DSC2 SLC22A23 ANKRD20A2P ANKRD20A3P ANKRD20A4P GPR157 EHF ZC3H12C ANKRD20A1 | 6.58e-10 | 198 | 138 | 10 | da84c76afe835aeee39da04b63c03549218b5d91 |
| ToppCell | mLN-Dendritic_cell-Lymphoid_DC|mLN / Region, Cell class and subclass | PLBD1 DSC2 SLC22A23 ANKRD20A2P ANKRD20A3P ANKRD20A4P GPR157 EHF ZC3H12C ANKRD20A1 | 6.58e-10 | 198 | 138 | 10 | 3965a9f1e8a51a196e5349aaca5fa5ed1cd8ee92 |
| ToppCell | Control-Myeloid-cDC1|Myeloid / Disease state, Lineage and Cell class | DPP4 CXCR3 ANKRD20A2P ANKRD20A3P ANKRD20A8P ANKRD20A4P GPR157 ANKRD20A1 | 1.13e-07 | 184 | 138 | 8 | c6affa0b12510363258f65e46bf2d47bf4a8e75f |
| ToppCell | (53)_Lymphoid_DC|World / shred on Cell_type and subtype | DSC2 SLC22A23 ANKRD20A2P ANKRD20A3P GPR157 RIN2 ZC3H12C ANKRD20A1 | 2.89e-07 | 208 | 138 | 8 | 30212cfacad94a7cc562a69efa73a31259851515 |
| ToppCell | COVID-19-Heart-Neuronal|Heart / Disease (COVID-19 only), tissue and cell type | 1.17e-06 | 173 | 138 | 7 | 6fb5f9e6536a5d57fd8e6657b494047a2d0bc9c7 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2-Exc_L5-6_FEZF2_ANKRD20A1|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.21e-06 | 174 | 138 | 7 | 99eb5e1aee136c7039e23b68a43a0fa3d775859f | |
| ToppCell | Children_(3_yrs)-Epithelial-lung_goblet_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.64e-06 | 182 | 138 | 7 | 3f1a666fe27dd7529c114539ed5f6b8ca585c875 | |
| ToppCell | wk_15-18-Epithelial-PNS-intermediate_Schwann|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.70e-06 | 183 | 138 | 7 | d874aa9a856f79626c8a8371f6196a77b7d662ee | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.03e-06 | 188 | 138 | 7 | 3cee9916399e2e7580cecbcbb27424a71e7e7ac0 | |
| ToppCell | COPD-Myeloid-cDC1|Myeloid / Disease state, Lineage and Cell class | DPP4 ANKRD20A2P ANKRD20A3P ANKRD20A8P ANKRD20A4P GPR157 ANKRD20A1 | 2.26e-06 | 191 | 138 | 7 | 3480e6d27dd4291765bbbb2acdb6a2e4f02c8085 |
| ToppCell | Mild-CD8+_T|Mild / Disease group and Cell class | 2.50e-06 | 194 | 138 | 7 | c3dba9ff0ab98b6a955b32d071ad7e397dcdc6e9 | |
| ToppCell | Mild-CD8+_T|World / Disease group and Cell class | 2.50e-06 | 194 | 138 | 7 | d64c2efb482bcdef9240977eae1023c4191286e7 | |
| ToppCell | Bronchial-NucSeq-Stromal-Schwann|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.68e-06 | 196 | 138 | 7 | a90c76d9c57a4491b94a321ba541b792ec5d8e83 | |
| ToppCell | Bronchial-NucSeq-Stromal-Schwann-Schwann_nonmyelinating|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.77e-06 | 197 | 138 | 7 | 4a7ff67bb0754e034e6f2a1bd34cde86ee3ef899 | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA-|Macroglial / cells hierarchy compared to all cells using T-Statistic | 3.06e-06 | 200 | 138 | 7 | f17b5a54e8f9eba9dcd0808ba4e8d275ac41bce2 | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA--|Macroglial / cells hierarchy compared to all cells using T-Statistic | 3.06e-06 | 200 | 138 | 7 | cc3409518f8b436ea92deb955e81114b3f410ff7 | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA|Macroglial / cells hierarchy compared to all cells using T-Statistic | 3.06e-06 | 200 | 138 | 7 | c24a3099e3d96d8b72f6d05286bb355d661a0377 | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA---|Macroglial / cells hierarchy compared to all cells using T-Statistic | 3.06e-06 | 200 | 138 | 7 | 4fc3de4bff7ed2bf40b38462c4b4e9b87af6a4ca | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA----L1-6|Macroglial / cells hierarchy compared to all cells using T-Statistic | 3.06e-06 | 200 | 138 | 7 | 310cd53db1c137f6af74e6ae682221d7ac27310c | |
| ToppCell | Macroglial-Polydendrocytes|Macroglial / cells hierarchy compared to all cells using T-Statistic | 3.06e-06 | 200 | 138 | 7 | 961858738ce35db8760c8c2e136f8369bc444ccf | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Imm)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 7.43e-06 | 150 | 138 | 6 | 0205318a870e091add66ee4305747dda9f51510d | |
| ToppCell | Basal_cells-Donor_02|World / lung cells shred on cell class, cell subclass, sample id | 8.01e-06 | 152 | 138 | 6 | 72499e4d2b374ef5f1621c89d94727ecf4bd4d5d | |
| ToppCell | LV-16._Neuronal|World / Chamber and Cluster_Paper | 1.28e-05 | 165 | 138 | 6 | 6ed52cb756d21addf46c7f6c457458b01339fe04 | |
| ToppCell | COVID-19-Heart-Neuronal|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.42e-05 | 168 | 138 | 6 | 88c2c574f428c2502b5fe099bd73b0758f668ef6 | |
| ToppCell | facs-Diaphragm-Limb_Muscle-24m|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.47e-05 | 169 | 138 | 6 | 12bdc709bc000d7f9061ecd9fbd57233eaacb7e2 | |
| ToppCell | E15.5-Epithelial-epithelial_progenitor_cell-epithelial_unknown_3|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.62e-05 | 172 | 138 | 6 | a8b33d8ebc56e442a2ad6ac7dafd0c887571bd95 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Medullary_Thick_Ascending_Limb_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.79e-05 | 175 | 138 | 6 | e5467dacf81f1f913b1719931cf1a7331434a7e7 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.97e-05 | 178 | 138 | 6 | be4976bbfd9ebbc568155ede99a07670c43aa372 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c02-GPR183|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.97e-05 | 178 | 138 | 6 | 91bf3c7c05d2e67ee590389a1b36c517d0ed7ebf | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_4-Exc_L4-5_RORB_RPL31P31|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.03e-05 | 179 | 138 | 6 | b35a7f8115c997c390201da01d7cb10b10769aec | |
| ToppCell | droplet-Kidney-nan-18m-Epithelial-podocyte|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.23e-05 | 182 | 138 | 6 | 9fc2f84bf70ad9a11c8a7326bd101e6f6cbcc33e | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Medullary_Thick_Ascending_Limb_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.23e-05 | 182 | 138 | 6 | 041bc819e6cf2618bf86bce8dfe2df673f392ba3 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.30e-05 | 183 | 138 | 6 | 31ab55d5f3639f5964541d5eae23044dbda3356e | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Epithelial-Epcam____podocyte-2|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.37e-05 | 184 | 138 | 6 | e123ad8ee46a032825a0bd4b3586ddcb3eda03d4 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Macula_Densa_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.37e-05 | 184 | 138 | 6 | d33de57876817050b294f2ecb0a4eb0634cfa7f0 | |
| ToppCell | COPD-Myeloid-cDC1|World / Disease state, Lineage and Cell class | ANKRD20A2P ANKRD20A3P ANKRD20A8P ANKRD20A4P GPR157 ANKRD20A1 | 2.37e-05 | 184 | 138 | 6 | 42d7ce104cd7bcb83fbbbd0e7d3267ad07edfa94 |
| ToppCell | wk_08-11-Mesenchymal-Myofibro_&_SMC-ACTC+_SMC|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 2.37e-05 | 184 | 138 | 6 | 39168ca2bbf1369c9fe87c67f0aaff5e3cd03151 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.44e-05 | 185 | 138 | 6 | 898a093757f86be3e18d2ef1f16a71f50ef81dc3 | |
| ToppCell | IPF-Myeloid-cDC1|World / Disease state, Lineage and Cell class | ANKRD20A2P ANKRD20A3P ANKRD20A8P ANKRD20A4P GPR157 ANKRD20A1 | 2.52e-05 | 186 | 138 | 6 | 962c2dada19185628ead77c32fcb07fa95114247 |
| ToppCell | facs-Trachea-18m-Mesenchymal-fibroblast-fibroblast_of_trachea-|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.52e-05 | 186 | 138 | 6 | bdc87e4631a8ea73e262e541aa84a28f24c94b00 | |
| ToppCell | Control-Myeloid-cDC1|Control / Disease state, Lineage and Cell class | ANKRD20A2P ANKRD20A3P ANKRD20A8P ANKRD20A4P GPR157 ANKRD20A1 | 2.52e-05 | 186 | 138 | 6 | b05c394aa3573ba855abc3066739ca193883b0c3 |
| ToppCell | IPF-Myeloid-cDC1|Myeloid / Disease state, Lineage and Cell class | ANKRD20A2P ANKRD20A3P ANKRD20A8P ANKRD20A4P GPR157 ANKRD20A1 | 2.67e-05 | 188 | 138 | 6 | 47bb6caf84f70a1cda7d09803afdfd5182772e66 |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Cortical_Thick_Ascending_Limb_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.67e-05 | 188 | 138 | 6 | 2ee64bc73a2251fd9f374be759b442cf4ed0d19e | |
| ToppCell | IPF-Myeloid-cDC1|IPF / Disease state, Lineage and Cell class | ANKRD20A2P ANKRD20A3P ANKRD20A8P ANKRD20A4P GPR157 ANKRD20A1 | 2.67e-05 | 188 | 138 | 6 | 2331a2bae1383820d598e93aa86c75b101069bac |
| ToppCell | facs-Brain_Myeloid-Striatum-3m-Myeloid-nan|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.75e-05 | 189 | 138 | 6 | 6dd4ec5ce4beb856f0d2d1654e3c4676d1d63736 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.75e-05 | 189 | 138 | 6 | e9d5e858e320c6e9913c1ea6a54967d21eda605f | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Macula_Densa_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.75e-05 | 189 | 138 | 6 | e059be2965cca70ff5576df055d0af1775b76e00 | |
| ToppCell | facs-Brain_Myeloid-Striatum-3m-Myeloid|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.75e-05 | 189 | 138 | 6 | 3ae479ec7e00c57127cbe51a398329b10ca9848c | |
| ToppCell | facs-Brain_Myeloid-Striatum-3m-Myeloid-microglial_cell|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.75e-05 | 189 | 138 | 6 | 875df61ee48baa5142ba4d2427bdec1c53e5a828 | |
| ToppCell | facs-Brain_Myeloid-Striatum-3m|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.75e-05 | 189 | 138 | 6 | 97ef5215d841ff366a3e3682cd9bd04100cbfde0 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.84e-05 | 190 | 138 | 6 | bf4511395fa97efd1c1cd17cc9bebb0271ee7f0e | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.84e-05 | 190 | 138 | 6 | b6b8964b4910083499681b5fdf554e127b6a4c4e | |
| ToppCell | facs-GAT-Fat-3m|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.84e-05 | 190 | 138 | 6 | 1d92be1b41cff59e834a9d28868f554bd1f3e471 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Epithelial-Pecam____Kidney_cortex_artery_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.92e-05 | 191 | 138 | 6 | b9ae5af426e7a1f2652a47700bb168371bd2dec6 | |
| ToppCell | COPD-Myeloid-cDC1|COPD / Disease state, Lineage and Cell class | ANKRD20A2P ANKRD20A3P ANKRD20A8P ANKRD20A4P GPR157 ANKRD20A1 | 3.01e-05 | 192 | 138 | 6 | bd3d00b094d92463b06023361a71240851a542b8 |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.01e-05 | 192 | 138 | 6 | 562df5e87038c500dd3a003fe5374cb31946b145 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.19e-05 | 194 | 138 | 6 | 89b706af2b25991fc2707eb24f49ba6ff3ae01f7 | |
| ToppCell | Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_granulocytic-neutrophil|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 3.28e-05 | 195 | 138 | 6 | d3755929ebbbf5e3afde44281e9056ddb614a291 | |
| ToppCell | Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_granulocytic|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 3.28e-05 | 195 | 138 | 6 | 19853c654ac64b3ae3bc99841c6cb29c8aaba85c | |
| ToppCell | 5'-Adult-SmallIntestine-Epithelial-Tuft-related-BEST4+_epithelial|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.28e-05 | 195 | 138 | 6 | e87b11e3242fdbed2e7f383e6876ec375af32bd4 | |
| ToppCell | COVID-19-kidney-TAL|kidney / Disease (COVID-19 only), tissue and cell type | 3.38e-05 | 196 | 138 | 6 | 04f5eb206ed3016a737609a3ebac0c1fcabb94ef | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.38e-05 | 196 | 138 | 6 | 676c56b44ac29f7baecb62f49bb8597cc74c0a88 | |
| ToppCell | Parenchymal-10x5prime-Stromal-Mesofibroblastic|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.47e-05 | 197 | 138 | 6 | 88a86286b9c3ea3b076d7464faec42d0392ee7f8 | |
| ToppCell | Parenchymal-10x5prime-Stromal-Mesofibroblastic-Mesothelia|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.47e-05 | 197 | 138 | 6 | 2773d2eb5f232a7e49da116efffcb6bf5eb90810 | |
| ToppCell | Tracheal-NucSeq-Stromal-Schwann-Schwann_nonmyelinating|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.47e-05 | 197 | 138 | 6 | 5c88a97e8e23a5cd61885acbe1ef339ae6a1e35a | |
| ToppCell | Tracheal-NucSeq-Stromal-Schwann|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.47e-05 | 197 | 138 | 6 | c1b2a3fbd5f4aeb3555d8c372efc86f1052e7c65 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.57e-05 | 198 | 138 | 6 | c01091ef18e096d792ea2a7a715764a5b215355f | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.57e-05 | 198 | 138 | 6 | 6d18b45eda4014759e6dd282d78ffd28df8a6044 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.57e-05 | 198 | 138 | 6 | 8ab40fae14fe02e39bc8c8da187a5cd60c787643 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.57e-05 | 198 | 138 | 6 | 4ca5ff320905ab4ff60ed90a5522227c782142a6 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.57e-05 | 198 | 138 | 6 | 0ff30edfd3c133a42e8cb96e1631a1143215f808 | |
| ToppCell | mLN-(5)_Dendritic_cell|mLN / shred on region, Cell_type, and subtype | 3.67e-05 | 199 | 138 | 6 | 4feecf533e29a1a558f1018a2e8f7bfa7b9d3864 | |
| ToppCell | mLN-Dendritic_cell|mLN / Region, Cell class and subclass | 3.67e-05 | 199 | 138 | 6 | 597412beae1324b9c43ca2bb96c4cb645c19f3e9 | |
| ToppCell | 10x_3'_v3-thymus_(10x_3'_v3)-myeloid|thymus_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 3.67e-05 | 199 | 138 | 6 | 0f3ce61bbae69f7e333ed8dacf7257645624e163 | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 3.78e-05 | 200 | 138 | 6 | e8db082aa4d0597500e4f16a5c0ea3e62c6c59ae | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_airway-airway_epithelial-Ciliated|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 3.78e-05 | 200 | 138 | 6 | 96701a4d57753f5ec0dd5c7550054bbcc946bc5f | |
| ToppCell | Neuronal|World / cells hierarchy compared to all cells using T-Statistic | 3.78e-05 | 200 | 138 | 6 | 48d801219bc771d6c7e151dc88ca4c179988de85 | |
| ToppCell | COVID-19-kidney-Epithelial_Doublet|COVID-19 / Disease (COVID-19 only), tissue and cell type | 5.31e-05 | 130 | 138 | 5 | 1ff28e9d3dc9a791e07d815f8fbb48f75d3f275b | |
| ToppCell | COVID-19-B_cells-B_cells|COVID-19 / group, cell type (main and fine annotations) | 5.31e-05 | 130 | 138 | 5 | 267b06a0db31e2664cf595cd737402da07ab51cd | |
| ToppCell | COVID-19-kidney-Technical/muscle_(PCT)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 7.30e-05 | 139 | 138 | 5 | a1945b07f177cde40e7eea03a19236ce76165857 | |
| ToppCell | 343B-Epithelial_cells-Epithelial-E_(AT2)-|343B / Donor, Lineage, Cell class and subclass (all cells) | 8.91e-05 | 145 | 138 | 5 | 80684ec249fa445c1b35f94608a4a6824d53f2d9 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_B-B_cell-B_c02-MS4A1-CD27|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.91e-05 | 145 | 138 | 5 | b17699f7f98d2361a4d26c26f52db05e7ff69dff | |
| ToppCell | facs-Lung-Endomucin-24m-Endothelial-Capillary_Type_1_Cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.91e-05 | 145 | 138 | 5 | 96712c68ab759d7ade0d912581a1a7c25dc6def8 | |
| ToppCell | 343B-Epithelial_cells-Epithelial-E_(AT2)|343B / Donor, Lineage, Cell class and subclass (all cells) | 8.91e-05 | 145 | 138 | 5 | cb534333fba44b241b14fb0d7b74e843f4e7f9f8 | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Mes)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 9.82e-05 | 148 | 138 | 5 | d6ac5972267254651dfbe16bb4e9a62228093cc7 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_airway-Ciliated_cells|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.22e-04 | 155 | 138 | 5 | 5f1e2195a6b831e1b636f5cc3a282ca423721822 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_airway-Ciliated_cells-Ciliated|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.22e-04 | 155 | 138 | 5 | 0944429459f642a1bcc56edc1ec28aaecde3e2dc | |
| ToppCell | PND14-Immune-Immune_Myeloid-DC-cDC1-cDC1_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.46e-04 | 161 | 138 | 5 | afc719ffa53ab34c5628da47936da1f731dceab1 | |
| ToppCell | Children_(3_yrs)-Epithelial-lung_goblet_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.46e-04 | 161 | 138 | 5 | 2d63b279d9a5132e1c09b03930bf9039036d24a2 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Neural-neural_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.50e-04 | 162 | 138 | 5 | d28b2ea1d2c8f3c6a107991573471b6d0c49c4ae | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Neural-neural_cell-Schwann_Cell_/_Neural-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.50e-04 | 162 | 138 | 5 | 5bbd7130d4dad9035e73a439dda568195c136f31 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Neural-neural_cell-Schwann_Cell_/_Neural|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.50e-04 | 162 | 138 | 5 | eed223e61c8162a2fe004ab4e09de5e037be7553 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Neural|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.50e-04 | 162 | 138 | 5 | e35ddce830e20ebeac1a2c405293fc4a5323dd4a | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Macula_Densa_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.50e-04 | 162 | 138 | 5 | 373513f9d0e5007b2e10a8b78d4909dcce9e3b62 | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Neuronal-neuron_precursor|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.54e-04 | 163 | 138 | 5 | 99cf60dc87f7ce288553091bffcd85109a02bd8f | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Neuronal-neuron_precursor-Neuroblast|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.54e-04 | 163 | 138 | 5 | 510c0af66e82c5a8cf8edd0547dae4018a87dbbf | |
| ToppCell | tumor_Lung-T/NK_cells-Cytotoxic_CD8+_T|T/NK_cells / Location, Cell class and cell subclass | 1.59e-04 | 164 | 138 | 5 | 60fe6bb86afaebd92590135f08f5434ce0d8d73c | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_low-phase|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.68e-04 | 166 | 138 | 5 | 43f84d3cd58e93ce00c241656c4cba27604b4932 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Degenerative_Proximal_Tubule_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.73e-04 | 167 | 138 | 5 | 3edb0570e583bb527165bcd8a4c25a042054043b | |
| ToppCell | Adult-Epithelial-lung_goblet_cell-D122|Adult / Lineage, Cell type, age group and donor | 1.73e-04 | 167 | 138 | 5 | 6efbb2ef6adc8da5dd67210969f825f5cc8ed022 | |
| Disease | biliary atresia (implicated_via_orthology) | 1.72e-05 | 2 | 123 | 2 | DOID:13608 (implicated_via_orthology) | |
| Disease | childhood trauma measurement | 1.34e-04 | 24 | 123 | 3 | EFO_0007979 | |
| Disease | age at first sexual intercourse measurement | 2.11e-04 | 383 | 123 | 8 | EFO_0009749 | |
| Disease | intellectual disability (implicated_via_orthology) | 2.78e-04 | 75 | 123 | 4 | DOID:1059 (implicated_via_orthology) | |
| Disease | asthma | RAF1 DPP4 TRPC3 CSMD3 NAALADL2 LRP1B SLC9A4 AP2A2 ITSN2 ILDR1 FTL | 3.15e-04 | 751 | 123 | 11 | MONDO_0004979 |
| Disease | autism spectrum disorder | 5.07e-04 | 156 | 123 | 5 | EFO_0003756 | |
| Disease | unipolar depression, bipolar disorder | 5.07e-04 | 156 | 123 | 5 | EFO_0003761, MONDO_0004985 | |
| Disease | neuroticism measurement, cognitive function measurement | DPP4 SLC22A23 GRIK3 LRP1B TENM3 PAFAH1B1 RBFOX1 SORCS3 PCDH9 | 6.27e-04 | 566 | 123 | 9 | EFO_0007660, EFO_0008354 |
| Disease | sleep time | 7.59e-04 | 10 | 123 | 2 | EFO_0005274 | |
| Disease | bronchopulmonary dysplasia | 8.83e-04 | 45 | 123 | 3 | MONDO_0019091 | |
| Disease | Night blindness, congenital stationary, type 1 | 1.11e-03 | 12 | 123 | 2 | C3501847 | |
| Disease | Night Blindness, Congenital Stationary, Type 1A | 1.11e-03 | 12 | 123 | 2 | C3495587 | |
| Disease | niacinamide measurement | 1.11e-03 | 12 | 123 | 2 | EFO_0010511 | |
| Disease | NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 2B (disorder) | 1.11e-03 | 12 | 123 | 2 | C1864877 | |
| Disease | NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1B | 1.11e-03 | 12 | 123 | 2 | C1850362 | |
| Disease | X-Linked Csnb | 1.11e-03 | 12 | 123 | 2 | C3711543 | |
| Disease | NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 2A | 1.11e-03 | 12 | 123 | 2 | C1848172 | |
| Disease | Amino Acid Metabolism, Inherited Disorders | 1.30e-03 | 13 | 123 | 2 | C0750905 | |
| Disease | Cone-rod synaptic disorder, congenital nonprogressive | 1.30e-03 | 13 | 123 | 2 | C4041558 | |
| Disease | Amino Acid Metabolism, Inborn Errors | 1.30e-03 | 13 | 123 | 2 | C0002514 | |
| Disease | Varicose veins | 1.32e-03 | 193 | 123 | 5 | HP_0002619 | |
| Disease | human papilloma virus infection, oropharynx cancer | 1.42e-03 | 53 | 123 | 3 | EFO_0001668, EFO_1001931 | |
| Disease | attention deficit hyperactivity disorder, autism spectrum disorder, intelligence | 1.43e-03 | 398 | 123 | 7 | EFO_0003756, EFO_0003888, EFO_0004337 | |
| Disease | cerebral atherosclerosis | 1.52e-03 | 14 | 123 | 2 | EFO_1000860 | |
| Disease | parathyroid hormone measurement | 1.58e-03 | 55 | 123 | 3 | EFO_0004752 | |
| Disease | age at first birth measurement | 1.63e-03 | 120 | 123 | 4 | EFO_0009101 | |
| Disease | unipolar depression, autism spectrum disorder | 1.75e-03 | 15 | 123 | 2 | EFO_0003756, EFO_0003761 | |
| Disease | lower body strength measurement | 1.99e-03 | 16 | 123 | 2 | EFO_0007999 | |
| Disease | resting metabolic rate measurement | 1.99e-03 | 16 | 123 | 2 | EFO_0008004 | |
| Disease | mood instability measurement | 2.06e-03 | 128 | 123 | 4 | EFO_0008475 | |
| Disease | depressive symptom measurement | 2.11e-03 | 426 | 123 | 7 | EFO_0007006 | |
| Disease | response to opioid | 2.13e-03 | 61 | 123 | 3 | EFO_0008541 | |
| Disease | Night blindness, congenital stationary | 2.25e-03 | 17 | 123 | 2 | C0339535 | |
| Disease | unipolar depression, mood disorder | 2.43e-03 | 134 | 123 | 4 | EFO_0003761, EFO_0004247 | |
| Disease | cannabis dependence | 2.50e-03 | 135 | 123 | 4 | EFO_0007191 | |
| Disease | autoimmune thyroid disease, systemic lupus erythematosus, type 1 diabetes mellitus, ankylosing spondylitis, psoriasis, common variable immunodeficiency, celiac disease, ulcerative colitis, Crohn's disease, autoimmune disease, juvenile idiopathic arthritis | 3.16e-03 | 70 | 123 | 3 | EFO_0000384, EFO_0000676, EFO_0000729, EFO_0001060, EFO_0002609, EFO_0003898, EFO_0005140, EFO_0006812, MONDO_0005147, MONDO_0007915, MONDO_0015517 | |
| Disease | Alzheimer disease, age at onset | 3.22e-03 | 343 | 123 | 6 | EFO_0004847, MONDO_0004975 | |
| Disease | fat intake measurement | 3.77e-03 | 22 | 123 | 2 | EFO_0010809 | |
| Disease | worry measurement | 4.01e-03 | 154 | 123 | 4 | EFO_0009589 | |
| Disease | major depressive disorder | 4.10e-03 | 155 | 123 | 4 | MONDO_0002009 | |
| Disease | autosomal dominant compelling helio-ophthalmic outburst syndrome | 4.13e-03 | 77 | 123 | 3 | EFO_0007887 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| IYGNTALHYAVYSES | 131 | Q5TYW2 | |
| VAALLENFSSSYDYG | 16 | P49682 | |
| NNLIASESYYTYASI | 1106 | Q6ZRH7 | |
| LAASGIYFYSNKYLD | 16 | Q86TW2 | |
| TYDAYSTFYLNSSGL | 256 | Q5SQH8 | |
| IYGNTALHYAVYSES | 131 | Q5CZ79 | |
| YCDAGYVLQGYSTLT | 1726 | Q7Z407 | |
| LLTVFAYGTYADYLA | 66 | Q9UBW8 | |
| AYGTYADYLAEARNL | 71 | Q9UBW8 | |
| RYYEVLGAAATTDYN | 296 | P46379 | |
| SQESLLLGDVAYYDY | 251 | Q9UEY8 | |
| IYGNTALHYAVYSES | 131 | Q4UJ75 | |
| IYGNTALHYAVYSES | 131 | A0PJZ0 | |
| SVYAVYARTDNLSSY | 5891 | Q8WXG9 | |
| IVSSASTDLQDYTYY | 236 | O95782 | |
| FLTNESGYYLDISLY | 1531 | Q13085 | |
| YLSSSNIINDGFYDY | 561 | Q5W041 | |
| SAGVLATLRNYDYYA | 281 | O95861 | |
| ELYTEASGYISSLEY | 196 | P00736 | |
| SSYDLGYTAAYTSYA | 106 | Q07687 | |
| IDYQAGDTYVSTSDY | 1321 | Q14004 | |
| YAYVDFNYSGNLLAS | 231 | Q96MT7 | |
| SDTAQNYTIYYSIRG | 161 | Q02487 | |
| IVTSASTDLQDYTYY | 236 | O94973 | |
| SFQSDVYSYGIVLYE | 526 | P04049 | |
| SEISIYDSTNYRYAS | 856 | Q6ZP01 | |
| YEAVAAAAASVYNYA | 231 | Q9BWF3 | |
| SYYRSANGAILAYDI | 86 | Q86YS6 | |
| AAYSDSYGRVYAAAD | 281 | A6NFN3 | |
| TSAAYSVGEEYIALY | 976 | Q9NZM3 | |
| YVTYGSEASAFYSLN | 86 | P78413 | |
| ADYLRSNGYEEAYSV | 16 | P43034 | |
| YDQSENLSGYLSDYS | 161 | P29074 | |
| LDYNAGLLSYYTSKD | 26 | Q96SU4 | |
| IYGNTALHYAVYSES | 131 | Q5SQ80 | |
| YGILYAYISTLNIDD | 321 | Q8N635 | |
| SKALNLAYSSIYGSY | 891 | Q7L576 | |
| YSLDYDQALAVVYSV | 266 | Q8NGY5 | |
| YTSLLYLSNYLEDFG | 241 | Q6PK18 | |
| LDSLYYLSVNGNYIS | 486 | A4D1F6 | |
| LSAIYSQLGNAYFYL | 61 | P81274 | |
| LYGITVFEDYLYATN | 416 | Q9NZR2 | |
| AYYESGYNTTAQTVL | 51 | Q6UWQ5 | |
| AYYESGYNTTAQTVL | 51 | Q7Z4W2 | |
| LSLQEFVAAAYYYGA | 456 | Q7RTR2 | |
| SLYNICYYALLASLS | 306 | A0A1B0GTS1 | |
| EYQLNDSAGYYLSDL | 141 | P11488 | |
| LSGINAINYYADTIY | 296 | Q6PXP3 | |
| AINYYADTIYTSAGV | 301 | Q6PXP3 | |
| ILQLAYDSTSYYSAN | 131 | P59045 | |
| ACYSLGNTYTLLQDY | 291 | Q86YR5 | |
| VNLYLQASYTYLSLG | 21 | P02792 | |
| GEFAYLYSQCYELTT | 406 | P14314 | |
| AETYASYFSAPNSYL | 371 | Q9HCE5 | |
| ASFYANSSTLYYQID | 426 | Q8WYN3 | |
| ADAEAAQYSYLGYAV | 451 | P38570 | |
| FYGYIRTNYSLAQSA | 56 | Q9NZN1 | |
| FLYVNDTAGNASYIY | 771 | Q9HC56 | |
| FDYYSASYQAALSLG | 71 | Q86SU0 | |
| SSIDLYFYVIGSSYE | 71 | P61923 | |
| ASGYYTIYDSETLQA | 1401 | Q9P265 | |
| GIEALTSDYLYYISN | 406 | P27487 | |
| AIDSVIFATGYDYSY | 321 | O60774 | |
| DDYYYGDISSLESSQ | 81 | Q9UGU5 | |
| SLYNICYYALLASLS | 306 | A0A1B0GWH4 | |
| SYVGIATLIANYSYT | 2081 | Q7Z6Z7 | |
| LAQTAAHVAGAAYYY | 116 | Q9Y4U1 | |
| LNFYASSLLFVYEGS | 246 | Q8NFU5 | |
| DIYLASQYTSYAISG | 496 | Q6P4A8 | |
| ALSADGYYARSEDYV | 421 | Q02809 | |
| DSLSTYINANYIRGY | 441 | Q15256 | |
| SVLDYLSYAVYQQGD | 206 | P13674 | |
| RQASSIYDDSYLGYS | 261 | P08648 | |
| VGYYLSICLSYASSS | 286 | Q969V1 | |
| IYGNTALHYAVYSES | 131 | Q5VUR7 | |
| FLLVDGSSIYLYSYE | 386 | Q9P2H3 | |
| HNLTIYFGSAYYVLT | 271 | Q6ZNI0 | |
| TSEAIESYYQRYLNG | 61 | Q9Y2V0 | |
| VVTGYLVYSASYEDF | 1686 | Q4ZHG4 | |
| AYLTGGDTIYLANYT | 296 | Q10981 | |
| ENYLYDTNYGSTVDL | 146 | Q9NZC4 | |
| GYRAIAYSSLSQSYL | 451 | P01031 | |
| ADLLSAASYFYGVLQ | 56 | Q5UAW9 | |
| YVSSYLAGATSADRY | 201 | Q5T5N4 | |
| SGVSIYFEAYLYNAT | 291 | O15033 | |
| YGFLYLALYAQVSQS | 46 | Q5VV63 | |
| SGSALYYTQSEDNIY | 296 | Q68D51 | |
| VTEYASLGSLYDYIN | 81 | Q9NYL2 | |
| SYDYDAVLTEAGDYT | 341 | Q8IW92 | |
| YKLTAYSLYAAVSVG | 116 | P19447 | |
| DTFYVNLYPDYASLS | 146 | Q13003 | |
| YLQLAASGAATAYFS | 171 | A6NK97 | |
| SNLAYYTAVRAYNSA | 871 | Q9P232 | |
| YLGIYLSDLTYIDSA | 201 | Q86X27 | |
| SYYFCIALGYTNSSL | 311 | P41145 | |
| SPLAADTSYYQGVYS | 436 | Q9Y261 | |
| GSQDYSLLQAYYSQE | 131 | Q8ND04 | |
| AAAYSDSYGRVYAAD | 326 | Q9NWB1 | |
| PAAGTYSYAQVSDYA | 246 | Q9H6I2 | |
| ISVLADATATYYNSY | 371 | Q9BT81 | |
| VYGSVYAIADISYSV | 416 | Q16572 | |
| YAIADISYSVAYALG | 421 | Q16572 | |
| KASYYLAVFYETGLN | 571 | Q68CR1 | |
| YSSAVYSLEEQYLGL | 696 | Q3BBV2 | |
| YSSAVYSLEEQYLGL | 731 | P0DPF3 | |
| YSSAVYSLEEQYLGL | 731 | Q6P3W6 | |
| YSSAVYSLEEQYLGL | 1951 | Q6P3W6 | |
| YSSAVYSLEEQYLGL | 3171 | Q6P3W6 | |
| YSSAVYSLEEQYLGL | 391 | Q5TI25 | |
| YSSAVYSLEEQYLGL | 1436 | A0A087WUL8 | |
| YSSAVYSLEEQYLGL | 2656 | A0A087WUL8 | |
| YSSAVYSLEEQYLGL | 116 | P0DPF2 | |
| YSSAVYSLEEQYLGL | 1336 | P0DPF2 | |
| YSSAVYSLEEQYLGL | 2556 | P0DPF2 | |
| YSSAVYSLEEQYLGL | 3776 | P0DPF2 | |
| YSSAVYSLEEQYLGL | 4996 | P0DPF2 | |
| YSSAVYSLEEQYLGL | 691 | B4DH59 | |
| PLYTQTASTSYYEAA | 321 | P22670 | |
| NDTYNLYISDTRGIY | 456 | Q9UPU3 | |
| YADYYTTASIALVSC | 466 | A1A5C7 | |
| TYYLQTYGSATQDLI | 176 | Q6ZW05 | |
| YLSYLAAETLYLSGI | 311 | Q6AI14 | |
| ADYNYISAIEAGAFS | 141 | Q9H156 | |
| AYSPYTLDSTQNVYS | 91 | Q96T21 | |
| LYSLDGRLLSTYSAY | 206 | Q9P2S5 | |
| YGYANTSEVRELYDA | 1231 | P14410 | |
| GSYVDYFSSSLYQAL | 676 | P23327 | |
| LAVGSNDYYISVYSV | 1316 | Q8N122 | |
| ELSLGSYEYVATLDY | 416 | O94855 | |
| YYLTSAYGALSLIKN | 736 | Q8WYP3 | |
| AAEEQATGSKSLYYY | 61 | Q8N609 | |
| LASSVLQYGYEYAFL | 196 | Q8NCC5 | |
| GDIALALYSALFSYS | 226 | Q9UM01 | |
| LVAAQSYLYSGSYQT | 526 | Q6Q0C0 | |
| LYYDSYTSSVVLESG | 66 | A0A0C4DH28 | |
| LVTGDYLYNFSYSND | 1536 | Q9P273 | |
| EALSYLVYAYQSNAA | 916 | Q96RU2 | |
| ISSESGHYYSYARNI | 851 | Q8NB14 | |
| NGEYAEAEALYSAYI | 21 | Q5I0X7 | |
| QSSINSADGYSLYRY | 1261 | Q7Z4N2 | |
| ATEEQATESVSLYYY | 61 | Q15629 | |
| RGEYLYTYDSQITDS | 196 | P17098 | |
| TYCLNYSAAIFYLES | 391 | Q6ZR37 | |
| LYYDSYNSRVVLESG | 66 | A0A0C4DH27 | |
| SSDSYVGYNDRSYVS | 636 | Q9C0D7 | |
| LYSYYLGAKVNAAFT | 586 | Q13507 | |
| AASAITGYLSYNDIY | 36 | O14657 | |
| DDYGALFSQYSSTLY | 81 | O75132 | |
| SQDLLYSYAAYSAKG | 256 | Q58DX5 |